Oroxat is indicated for the treatment of symptomatic anemia in adult patients associated with chronic kidney disease (CKD).
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Oroxat (Roxadustat) is the first-in-class orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It promotes erythropoiesis by:
Roxadustat inhibits HIF prolyl hydroxylase enzymes (HIF-PH), preventing the degradation of hypoxia-inducible factor (HIF) transcription factors. This increases HIF activity, leading to:
For Patients Not on Erythropoiesis-Stimulating Agents:
For Patients Switching from Erythropoiesis-Stimulating Agents:
Dose Adjustments:
Can be taken with or without food.
Phosphate Binders or Multivalent Cation-Containing Products:
Gemfibrozil or Probenecid:
Statins (Simvastatin, Rosuvastatin, Atorvastatin):
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.